Plastic composition with anti-hemolytic effect

Claims

What is claimed is:

1. A flexible, plastic container having at least a portion of the interior surface thereof defined by a composition comprising a non-PVC copolymer and a citrate ester, the quantity of said citrate ester being sufficient to suppress hemolysis of red blood cells stored within said container.

2. A plastic container in accordance with claim 1 wherein said citrate ester provides a controlled leaching of said citrate ester into the blood in order to suppress the hemolysis of red blood cells.

3. A plastic container in accordance with claim 1 wherein said non-PVC plastic is a polyolefin copolymer.

4. A plastic container in accordance with claim 3 wherein said polyolefin copolymer comprises:

a block copolymer, having thermoplastic rubber characteristics, consisting essentially of (1) a central block, comprising 50% to 85% by weight of the copolymer molecule, of a rubbery olefin polymer of generally equal proportions of ethylene and butylene units, and (2) terminal blocks of polystyrene.

5. A plastic container in accordance with claim 1 wherein said citrate ester is selected from the group consisting of acetyltri-n-hexyl citrate, n-butyryltri-n-hexyl citrate, acetyltri-n-(hexyl/ octyl/decyl) citrate, and acetyltri-n-(octyl/decyl) citrate.

6. A plastic container in accordance with claim 1 wherein said citrate ester is n-butyryltri-n-hexyl citrate.

7. A plastic container in accordance with claim 3 wherein said composition further comprises a selected quantity of polyolefin consisting essentially of propylene units.

8. A plastic container in accordance with claim 7 wherein said composition comprises from 20% to 30% polyolefin consisting essentially of propylene units.

9. A plastic container in accordance with claim 7 wherein said composition comprises:

55% to 65% by weight of polyolefin copolymer

15% to 25% by weight of citrate ester;

20% to 30% by weight of polyolefin consisting of essentially propylene units.

10. A plastic container in accordance with claim 5 wherein said citrate ester has heat stability characteristics, after heating at 150.degree. C. for two hours, of a color not greater than 50 to 60 apha, and a mild odor at 25.degree. C. and has an aconitate level of less than about 0.2% when the esterification mixture from which said citrate is produced tests 0.5% maximum acidity when calculated as citric acid.

11. A plastic container in accordance with claim 5 wherein said citrate ester has a heat stability characteristic, after heating at 150.degree. C. for two hours, of a neutralization number mg. KOH/g, of not greater than about 0.2.

12. A plastic container in accordance with claim 1 wherein said container comprises a plurality of layers and wherein an innermost layer is of a plastic composition comprising a non-PVC plastic and a citrate ester, and wherein the outer layer is of a different material.

13. A plastic container in accordance with claim 12 wherein said innermost layer is an emulsion.

14. A plastic container in accordance with claim 1 wherein said container includes means defining a container wall and said wall is made solely of said composition.

15. A multi-bag system comprising at least two flexible containers, conduit means providing sealed flow communication between said containers and conduit means for receiving red blood cells into at least one of said containers, wherein said one of said containers has at least a portion of the interior surface thereof formed of a plastic composition comprising a non-PVC plastic and a citrate-ester, the quantity of said citrate ester being sufficient to suppress hemolysis of red blood cells stored within said one container.

16. A multi-bag system in accordance with claim 15 wherein said citrate ester provides a controlled leaching of said citrate ester into the blood in order to suppress the hemolysis of red blood cells.

17. A multi-bag system in accordance with claim 15 wherein said non-PVC plastic is a polyolefin copolymer.

18. A multi-bag system in accordance with claim 10 wherein the said polyolefin copolymer comprises:

a block copolymer, having thermoplastic rubber characteristics, consisting essentially of (1) a central block, comprising 50% to 85% by weight of the copolymer molecule, of a rubbery olefin polymer of generally equal proportions of ethylene and butylene units, and (2) terminal blocks of polystyrene.

19. A multi-bag system as described in claim 15 wherein said citrate ester is selected from the group consisting of acetyltri-n-hexyl citrate, n-butyryltri-n-hexyl citrate, acetyltri-n-(hexyl/octyl/decyl) citrate and acetyltri-n-(octyl/decyl) citrate.

20. A multi-bag system in accordance with claim 15 wherein said citrate ester is n-butyryltri-n-hexyl citrate.

21. A multi-bag system in accordance with claim 15 wherein the quantity of citrate ester is from 15% to 25% of dry weight.

22. A multi-bag system in accordance with claim 17 wherein said composition further comprises a selected quantity of polyolefin consisting essentially of propylene units.

23. A multi-bag system in accordance with claim 22 wherein said composition comprises:

20% to 30% by weight of said polyolefin consisting essentially of propylene units.

24. A multi-bag system in accordance with claim 22 wherein at least one of said containers comprises:

55% to 65% by weight of said polyolefin copolymer;

15% to 25% by weight of citrate ester;

20% to 30% by weight of polyolefin consisting essentially of propylene units.

25. A method of making a flexible, plastic container for storing red blood cells comprising:

providing a non-PVC plastic; mixing with said non-PVC plastic a citrate ester, the quantity of said citrate ester being sufficient to suppress hemolysis of red blood cells stored within said container;

extruding the resultant material into a film of a selected thickness;

forming said film into a selected container shape wherein said resultant material is co-extruded with a different material.

26. A method in accordance with claim 25 wherein said citrate ester provides a controlled leaching of said citrate ester into the blood in order to suppress the hemolysis of red blood cells.

27. A method in accordance with claim 25 wherein said non-PVC plastic is a polyolefin copolymer.

28. A method in accordance with claim 27 wherein the said polyolefin copolymer comprises:

a block copolymer, having thermoplastic rubber characteristics, consisting essentially of (1) a central block, comprising 50% to 85% by weight of the copolymer molecule, of a rubbery olefin polymer of generally equal proportions of ethylene and butylene units, and (2) terminal blocks of polystyrene.

29. A method as described in claim 25 wherein said material is a citrate ester selected from the group consisting of acetyltri-n-hexyl citrate, n-butyryltri-n-hexyl citrate, acetyltri-n-(hexyl/octyl/decyl) citrate and acetyltri-n-(octyl/decyl) citrate.

30. A method in accordance with claim 25 wherein said citrate ester is n-butyryltri-n-hexyl citrate.

31. A method in accordance with claim 25 wherein the quantity of citrate ester is from 15% to 25% of dry weight.

32. A method in accordance with claim 27 wherein said method further comprises the step of mixing with said polyolefin copolymer a selected quantity of polyolefin consisting essentially of propylene units.

33. A method in accordance with claim 32 wherein said resultant material comprises:

20% to 30% be weight of polyolefin consisting essentially of propylene units.

34. A method as described in claim 25 wherein said resultant material is co-extruded with a different material.

35. A method in accordance with claim 32 wherein said resultant material comprises:

55% to 65% by weight of said polyolefin copolymer;

15% to 25% by weight of citrate ester;

20% to 30% by weight of polyolefin consisting essentially of propylene units.

36. A method in accordance with claim 32 wherein said resultant material comprises:

55% by weight of said polyolefin copolymer;

15% by weight of n-butyryltri-n-hexyl citrate;

30% by weight of polyolefin consisting essentially of propylene units.

37. A method for suppressing hemolysis of red blood cells comprising the steps of:

providing a flexible, autoclavable, plastic container having at least a portion of the interior surface thereof formed of a composition comprising a non-PVC plastic and a citrate ester, the quantity of said citrate ester being sufficient to suppress hemolysis in red blood cells;

introducing a quantity of red blood cells into said container;

maintaining said quantity of red blood cells within said container for a selected period of time.

38. A method in accordance with claim 37 wherein said citrate ester provides a controlled leaching of said citrate ester into the blood in order to suppress the hemolysis of red blood cells.

39. A method in accordance with claim 35 wherein non-PVC plastic is a polyolefin copolymer.

40. A method in accordance with claim 39 wherein said polyolefin copolymer comprises:

a block copolymer, having thermoplastic rubber characteristics, consisting essentially of (1) a central block, comprising 50% to 85% by weight of the copolymer molecule, of a rubbery olefin polymer of generally equal proportions of ethylene and butylene units, and (2) terminal blocks of polystyrene.

41. A method in accordance with claim 37 wherein said citrate ester is selected from the group consisting of acetyltri-n-hexyl citrate, n-butyryltri-n-hexyl citrate, acetyltri-n-(hexyl/octyl/decyl) citrate and acetyltri-n-(octyl/decyl) citrate.

42. A method in accordance with claim 37 wherein said citrate ester is n-butyryltri-n-hexyl citrate.

43. A method in accordance with claim 37 wherein the composition comprises 15% to 25% citrate ester.

44. A method in accordance with claim 39 wherein said method further comprises the step of adding a polyolefin consisting essentially of propylene units.

45. A method in accordance with claim 44 wherein said composition comprises:

20% to 30% by weight of a polyolefin consisting essentially of propylene units.

46. A method in accordance with claim 44 wherein said composition comprises:

55% to 65% by weight of polyolefin copolymer;

15% to 25% by weight of citrate ester;

20% to 30% by weight of polyolefin consisting primarily of propylene units.

47. A method in accordance with claim 44 wherein at least a portion of the interior surface of said container comprises:

55% by weight of said polyolefin copolymer;

15% by weight of n-butyryltri-n-hexyl citrate;

30% by weight of said polyolefin consisting essentially of propylene units.

48. A method in accordance with claim 37 wherein said period of time is at least twenty-one days.

49. A plastic container in accordance with claim 20 comprising:

55% by weight of a polyolefin copolymer;

15% by weight of n-butyryltri-n-hexyl citrate ester;

30% by weight of polyolefin consisting essentially of propylene units.

50. A multi-bag system in accordance with claim 22 wherein said plastic composition comprises:

55% by weight of polyolefin copolymer;

15% by weight of n-butyryl-n-hexyl citrate;

30% by weight of polyolefin consisting essentially of propylene units.